Amyotrophic lateral sclerosis: a focus on disease progression

AC Calvo, R Manzano, DMF Mendonça… - BioMed research …, 2014 - Wiley Online Library
Since amyotrophic lateral sclerosis (ALS) was discovered and described in 1869 as a
neurodegenerative disease in which motor neuron death is induced, a wide range of …

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations

R Bowser, MR Turner, J Shefner - Nature Reviews Neurology, 2011 - nature.com
Insights into the mechanisms of amyotrophic lateral sclerosis (ALS) have relied
predominantly on the study of postmortem tissue. Modern technology has improved the …

Current view and perspectives in amyotrophic lateral sclerosis

S Mathis, P Couratier, A Julian, P Corcia… - Neural Regeneration …, 2017 - journals.lww.com
Amyotrophic lateral sclerosis (ALS), identified as a distinct clinical entity by Charcot since the
end of the nineteenth century, is a devastating and fatal neurodegenerative disorder that …

Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis

A Jimenez-Pacheco, JM Franco, S Lopez… - … in Aging and Disease, 2017 - Springer
Despite being clinically described 150 years ago, the mechanisms underlying amyotrophic
lateral sclerosis (ALS) pathogenesis have not yet been fully understood. Studies in both …

The 'omics' of amyotrophic lateral sclerosis

D Caballero-Hernandez, MG Toscano… - Trends in molecular …, 2016 - cell.com
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that primarily
affects motor neurons and is accompanied by sustained unregulated immune responses …

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation

RJ Mead, N Shan, HJ Reiser, F Marshall… - Nature Reviews Drug …, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) is a devastating disease caused by degeneration of
motor neurons. As with all major neurodegenerative disorders, development of disease …

Amyotrophic lateral sclerosis–looking for pathogenesis and effective therapy

E Naganska, E Matyja - Folia Neuropathologica, 2011 - termedia.pl
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
characterized by loss of motor neurons in the spinal cord, brain stem and motor cortex which …

New therapeutic targets for amyotrophic lateral sclerosis

M Kuzma-Kozakiewicz, H Kwiecinski - Expert opinion on …, 2011 - Taylor & Francis
Introduction: Amyotrophic lateral sclerosis (ALS) is one of the most devastating neurological
disorders, affecting approximately half a million people worldwide. Currently there is no cure …

Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy

MJ Strong - Expert opinion on investigational drugs, 2004 - Taylor & Francis
Among the neurodegenerative diseases associated with ageing, amyotrophic lateral
sclerosis (ALS) remains the most devastating. The disease inexorably progresses, the vast …

[PDF][PDF] Transcriptomics in amyotrophic lateral sclerosis

MG Krokidis, P Vlamos - Front Biosci (Elite Ed), 2018 - article.imrpress.com
Amyotrophic lateral sclerosis (ALS) is an adult-onset, incurable neurodegenerative disease
characterized by the selective death of upper and lowers motor neurons in the spinal cord …